Morgan Stanley’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-445,036
| Closed | -$12.7M | – | 6852 |
|
|
2018
Q4 | $12.7M | Buy |
445,036
+323,558
| +266% | +$9.19M | ﹤0.01% | 1866 |
|
|
2018
Q3 | $3.39M | Sell |
121,478
-134,886
| -53% | -$3.79M | ﹤0.01% | 3569 |
|
|
2018
Q2 | $7.15M | Sell |
256,364
-157,302
| -38% | -$4.22M | ﹤0.01% | 2748 |
|
|
2018
Q1 | $10.3M | Buy |
413,666
+201,904
| +95% | +$4.91M | ﹤0.01% | 2311 |
|
|
2017
Q4 | $5.13M | Sell |
211,762
-247,762
| -54% | -$6.53M | ﹤0.01% | 3090 |
|
|
2017
Q3 | $12.7M | Buy |
459,524
+300,730
| +189% | +$8.02M | ﹤0.01% | 2041 |
|
|
2017
Q2 | $3.98M | Sell |
158,794
-39,832
| -20% | -$986K | ﹤0.01% | 3105 |
|
|
2017
Q1 | $5.33M | Sell |
198,626
-52,727
| -21% | -$1.46M | ﹤0.01% | 2798 |
|
|
2016
Q4 | $6.59M | Buy |
251,353
+100,470
| +67% | +$2.48M | ﹤0.01% | 2708 |
|
|
2016
Q3 | $3.77M | Buy |
150,883
+112,133
| +289% | +$2.61M | ﹤0.01% | 2948 |
|
|
2016
Q2 | $839K | Sell |
38,750
-2,996
| -7% | -$53.5K | ﹤0.01% | 4107 |
|
|
2016
Q1 | $626K | Sell |
41,746
-25,428
| -38% | -$426K | ﹤0.01% | 4280 |
|
|
2015
Q4 | $1.47M | Buy |
67,174
+874
| +1% | +$16.3K | ﹤0.01% | 3756 |
|
|
2015
Q3 | $1.04M | Sell |
66,300
-13,042
| -16% | -$209K | ﹤0.01% | 4071 |
|
|
2015
Q2 | $1.13M | Buy |
79,342
+51,594
| +186% | +$874K | ﹤0.01% | 4102 |
|
|
2015
Q1 | $481K | Sell |
27,748
-8,240
| -23% | -$146K | ﹤0.01% | 4682 |
|
|
2014
Q4 | $645K | Sell |
35,988
-15,572
| -30% | -$251K | ﹤0.01% | 4492 |
|
|
2014
Q3 | $677K | Buy |
51,560
+41,644
| +420% | +$561K | ﹤0.01% | 4359 |
|
|
2014
Q2 | $143K | Sell |
9,916
-337
| -3% | -$4.4K | ﹤0.01% | 5322 |
|
|
2014
Q1 | $131K | Sell |
10,253
-27,628
| -73% | -$360K | ﹤0.01% | 5325 |
|
|
2013
Q4 | $380K | Buy |
37,881
+22,010
| +139% | +$250K | ﹤0.01% | 4648 |
|
|
2013
Q3 | $209K | Buy |
15,871
+577
| +4% | +$7.57K | ﹤0.01% | 4863 |
|
|
2013
Q2 | $218K | Buy |
+15,294
| New | +$192K | ﹤0.01% | 4797 |
|
Other funds holding NXTM
Morgan Stanley's NXTM Position: Q1 2019 in Review
Morgan Stanley sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 445,036 shares — an estimated $12.7M sold.
Morgan Stanley first reported a position in NXTM in Q2 2013 and held it in 23 quarters. The position peaked at $12.7M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Morgan Stanley reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Morgan Stanley sold 445,036 NxStage Medical Inc. shares in Q1 2019, an estimated $12.7M.
- Morgan Stanley first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 23 quarters.
- Morgan Stanley's NxStage Medical Inc. position peaked at $12.7M in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Morgan Stanley's 13F filing for Q1 2019, filed 15 May 2019.